KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
| Image |  |
|---|---|
| Description | scientific article published on 19 September 2019 |
| Author/s |
author: Christian W Eskelund Davide Rossi Kirsten Grønbæk Paola Ghione Armando Santoro Arne Kolstad Christina Dahl Mats Jerkeman Gianluca Gaidano |
| Publication date | September 19, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |